Clinical Trials in New York

Showing 3561-3580 of 22,668 trials

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

NCT04580420

The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.

Primary Hyperoxaluria Type 1End Stage Renal Disease

Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 participantsStarted Apr 2021

San Francisco, California, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +15 more locations

RECRUITINGPhase 4< 1 mile

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

NCT06468202

The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.

Hypertensive Disorders of PregnancyPreeclampsiaGestational Hypertension

Ohio State University10,742 participantsStarted Oct 2024

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +13 more locations

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Find Trials by Condition in New York

A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement

To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2

Stroke Thrombectomy and Aneurysm Registry

An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst

A Study of YL242 in Subjects With Advanced Solid Tumors

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Let's Know!2: Language-focused Intervention for Children at Risk of Comprehension Difficulties

Clinical and Molecular Studies in Families With Inherited Eye Disease

SpineTRACK Registry - Spinal Outcomes Registry

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

A Study of WVT078 in Patients With Multiple Myeloma (MM)